-
1
-
-
40949150889
-
-
NICE. Statins for the prevention of cardiovascular events. 2006.
-
NICE. Statins for the prevention of cardiovascular events. 2006.
-
-
-
-
2
-
-
34447537928
-
Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers
-
Howard-Alpe G.M., Sear J.W., and Foex P. Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers. British Journal of Anaesthesia 97 6 (2006 Dec) 758-769
-
(2006)
British Journal of Anaesthesia
, vol.97
, Issue.6
, pp. 758-769
-
-
Howard-Alpe, G.M.1
Sear, J.W.2
Foex, P.3
-
3
-
-
0028925078
-
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics
-
Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 9 (1995 May 1) 2488-2496
-
(1995)
Circulation
, vol.91
, Issue.9
, pp. 2488-2496
-
-
Berliner, J.A.1
Navab, M.2
Fogelman, A.M.3
-
4
-
-
0033552883
-
Atherosclerosis - an inflammatory disease
-
Ross R. Atherosclerosis - an inflammatory disease. The New England Journal of Medicine 340 2 (1999 Jan 14) 115-126
-
(1999)
The New England Journal of Medicine
, vol.340
, Issue.2
, pp. 115-126
-
-
Ross, R.1
-
5
-
-
0030000143
-
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease
-
Muhlestein J.B., Hammond E.H., Carlquist J.F., et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. Journal of the American College of Cardiology 27 7 (1996 Jun) 1555-1561
-
(1996)
Journal of the American College of Cardiology
, vol.27
, Issue.7
, pp. 1555-1561
-
-
Muhlestein, J.B.1
Hammond, E.H.2
Carlquist, J.F.3
-
6
-
-
0025125875
-
High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
-
Hendrix M.G., Salimans M.M., van Boven C.P., and Bruggeman C.A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. The American Journal of Pathology 136 1 (1990 Jan) 23-28
-
(1990)
The American Journal of Pathology
, vol.136
, Issue.1
, pp. 23-28
-
-
Hendrix, M.G.1
Salimans, M.M.2
van Boven, C.P.3
Bruggeman, C.A.4
-
7
-
-
0020961153
-
Excess deaths attributable to influenza in England and Wales: age at death and certified cause
-
Tillett H.E., Smith J.W., and Gooch C.D. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. International Journal of Epidemiology 12 3 (1983 Sep) 344-352
-
(1983)
International Journal of Epidemiology
, vol.12
, Issue.3
, pp. 344-352
-
-
Tillett, H.E.1
Smith, J.W.2
Gooch, C.D.3
-
8
-
-
0027933081
-
The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
-
Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. The New England Journal of Medicine 331 7 (1994 Aug 18) 417-424
-
(1994)
The New England Journal of Medicine
, vol.331
, Issue.7
, pp. 417-424
-
-
Liuzzo, G.1
Biasucci, L.M.2
Gallimore, J.R.3
-
9
-
-
0030948839
-
Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?
-
Vallance P., Collier J., and Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?. Lancet 349 9062 (1997 May 10) 1391-1392
-
(1997)
Lancet
, vol.349
, Issue.9062
, pp. 1391-1392
-
-
Vallance, P.1
Collier, J.2
Bhagat, K.3
-
10
-
-
0033813079
-
C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
-
Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arteriosclerosis Thrombosis and Vascular Biology 20 9 (2000 Sep) 2094-2099
-
(2000)
Arteriosclerosis Thrombosis and Vascular Biology
, vol.20
, Issue.9
, pp. 2094-2099
-
-
Torzewski, M.1
Rist, C.2
Mortensen, R.F.3
-
11
-
-
23744482481
-
C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events
-
Vainas T., Stassen F.R., de Graaf R., et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. Journal of Vascular Surgery 42 2 (2005 Aug) 243-251
-
(2005)
Journal of Vascular Surgery
, vol.42
, Issue.2
, pp. 243-251
-
-
Vainas, T.1
Stassen, F.R.2
de Graaf, R.3
-
12
-
-
0028240452
-
Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture
-
Fernandez-Ortiz A., Badimon J.J., Falk E., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. Journal of the American College of Cardiology 23 7 (1994 Jun) 1562-1569
-
(1994)
Journal of the American College of Cardiology
, vol.23
, Issue.7
, pp. 1562-1569
-
-
Fernandez-Ortiz, A.1
Badimon, J.J.2
Falk, E.3
-
13
-
-
0001495165
-
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
-
Wilcox J.N., Smith K.M., Schwartz S.M., and Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proceedings of the National Academy of Sciences of the United States of America 86 8 (1989 Apr) 2839-2843
-
(1989)
Proceedings of the National Academy of Sciences of the United States of America
, vol.86
, Issue.8
, pp. 2839-2843
-
-
Wilcox, J.N.1
Smith, K.M.2
Schwartz, S.M.3
Gordon, D.4
-
14
-
-
19244386852
-
Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction
-
Theroux P., and Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 97 12 (1998 Mar 31) 1195-1206
-
(1998)
Circulation
, vol.97
, Issue.12
, pp. 1195-1206
-
-
Theroux, P.1
Fuster, V.2
-
15
-
-
0034898476
-
Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches
-
Badimon L., Vilahur G., Sanchez S., and Duran X. Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches. European Heart Journal 3 Suppl. I (2001) I16-I22
-
(2001)
European Heart Journal
, vol.3
, Issue.SUPPL. I
-
-
Badimon, L.1
Vilahur, G.2
Sanchez, S.3
Duran, X.4
-
16
-
-
0026502668
-
Postoperative hypoxaemia after major abdominal vascular surgery
-
Reeder M.K., Goldman M.D., Loh L., et al. Postoperative hypoxaemia after major abdominal vascular surgery. British Journal of Anaesthesia 68 1 (1992 Jan) 23-26
-
(1992)
British Journal of Anaesthesia
, vol.68
, Issue.1
, pp. 23-26
-
-
Reeder, M.K.1
Goldman, M.D.2
Loh, L.3
-
17
-
-
0027474362
-
Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery
-
Landesberg G., Luria M.H., Cotev S., et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 341 8847 (1993 Mar 20) 715-719
-
(1993)
Lancet
, vol.341
, Issue.8847
, pp. 715-719
-
-
Landesberg, G.1
Luria, M.H.2
Cotev, S.3
-
18
-
-
0035368414
-
Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia
-
Landesberg G., Mosseri M., Zahger D., et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. Journal of the American College of Cardiology 37 7 (2001 Jun 1) 1839-1845
-
(2001)
Journal of the American College of Cardiology
, vol.37
, Issue.7
, pp. 1839-1845
-
-
Landesberg, G.1
Mosseri, M.2
Zahger, D.3
-
19
-
-
0030589106
-
Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention
-
Dawood M.M., Gutpa D.K., Southern J., et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. International Journal of Cardiology 57 1 (1996 Nov 15) 37-44
-
(1996)
International Journal of Cardiology
, vol.57
, Issue.1
, pp. 37-44
-
-
Dawood, M.M.1
Gutpa, D.K.2
Southern, J.3
-
20
-
-
0033067793
-
Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction
-
Cohen M.C., and Aretz T.H. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovascular Pathology 8 3 (1999 May-Jun) 133-139
-
(1999)
Cardiovascular Pathology
, vol.8
, Issue.3
, pp. 133-139
-
-
Cohen, M.C.1
Aretz, T.H.2
-
21
-
-
17844370780
-
Early and delayed myocardial infarction after abdominal aortic surgery
-
Le Manach Y., Perel A., Coriat P., et al. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 102 5 (2005 May) 885-891
-
(2005)
Anesthesiology
, vol.102
, Issue.5
, pp. 885-891
-
-
Le Manach, Y.1
Perel, A.2
Coriat, P.3
-
22
-
-
18944365864
-
Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques
-
Libby P. Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. Journal of the American College of Cardiology 45 10 (2005 May 17) 1600-1602
-
(2005)
Journal of the American College of Cardiology
, vol.45
, Issue.10
, pp. 1600-1602
-
-
Libby, P.1
-
23
-
-
0034727054
-
Multiple complex coronary plaques in patients with acute myocardial infarction
-
Goldstein J.A., Demetriou D., Grines C.L., et al. Multiple complex coronary plaques in patients with acute myocardial infarction. The New England Journal of Medicine 343 13 (2000 Sep 28) 915-922
-
(2000)
The New England Journal of Medicine
, vol.343
, Issue.13
, pp. 915-922
-
-
Goldstein, J.A.1
Demetriou, D.2
Grines, C.L.3
-
24
-
-
18944395623
-
Multiple plaque rupture and C-reactive protein in acute myocardial infarction
-
Tanaka A., Shimada K., Sano T., et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. Journal of the American College of Cardiology 45 10 (2005 May 17) 1594-1599
-
(2005)
Journal of the American College of Cardiology
, vol.45
, Issue.10
, pp. 1594-1599
-
-
Tanaka, A.1
Shimada, K.2
Sano, T.3
-
25
-
-
18944397795
-
Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction
-
Mauriello A., Sangiorgi G., Fratoni S., et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. Journal of the American College of Cardiology 45 10 (2005 May 17) 1585-1593
-
(2005)
Journal of the American College of Cardiology
, vol.45
, Issue.10
, pp. 1585-1593
-
-
Mauriello, A.1
Sangiorgi, G.2
Fratoni, S.3
-
26
-
-
0033539593
-
Independent prognostic value of elevated C-reactive protein in unstable angina
-
Ferreiros E.R., Boissonnet C.P., Pizarro R., et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 100 19 (1999 Nov 9) 1958-1963
-
(1999)
Circulation
, vol.100
, Issue.19
, pp. 1958-1963
-
-
Ferreiros, E.R.1
Boissonnet, C.P.2
Pizarro, R.3
-
27
-
-
0041846483
-
Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction
-
Correia L.C., Sposito A.C., Lima J.C., et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. American Journal of Cardiology 92 3 (2003 Aug 1) 298-301
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.3
, pp. 298-301
-
-
Correia, L.C.1
Sposito, A.C.2
Lima, J.C.3
-
28
-
-
0037458121
-
C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study
-
Beattie M.S., Shlipak M.G., Liu H., et al. C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation 107 2 (2003 Jan 21) 245-250
-
(2003)
Circulation
, vol.107
, Issue.2
, pp. 245-250
-
-
Beattie, M.S.1
Shlipak, M.G.2
Liu, H.3
-
29
-
-
0037454074
-
A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes
-
Topol E.J. A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology 41 4 Suppl. S (2003 Feb 19) S123-S129
-
(2003)
Journal of the American College of Cardiology
, vol.41
, Issue.4 SUPPL. S
-
-
Topol, E.J.1
-
31
-
-
0037012405
-
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study
-
Haim M., Tanne D., Boyko V., et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. Journal of the American College of Cardiology 39 7 (2002 Apr 3) 1133-1138
-
(2002)
Journal of the American College of Cardiology
, vol.39
, Issue.7
, pp. 1133-1138
-
-
Haim, M.1
Tanne, D.2
Boyko, V.3
-
32
-
-
1542284684
-
Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction
-
Jansson K., Redler B., Truedsson L., et al. Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction. American Journal of Surgery 187 3 (2004 Mar) 372-377
-
(2004)
American Journal of Surgery
, vol.187
, Issue.3
, pp. 372-377
-
-
Jansson, K.1
Redler, B.2
Truedsson, L.3
-
33
-
-
0032053582
-
Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications
-
van Berge Henegouwen M.I., van der Poll T., van Deventer S.J., and Gouma D.J. Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. American Journal of Surgery 175 4 (1998 Apr) 311-316
-
(1998)
American Journal of Surgery
, vol.175
, Issue.4
, pp. 311-316
-
-
van Berge Henegouwen, M.I.1
van der Poll, T.2
van Deventer, S.J.3
Gouma, D.J.4
-
34
-
-
4043079296
-
Ischaemia-reperfusion injury and regional inflammatory responses in abdominal aortic aneurysm repair
-
Norwood M.G., Bown M.J., and Sayers R.D. Ischaemia-reperfusion injury and regional inflammatory responses in abdominal aortic aneurysm repair. European Journal of Vascular and Endovascular Surgery 28 3 (2004 Sep) 234-245
-
(2004)
European Journal of Vascular and Endovascular Surgery
, vol.28
, Issue.3
, pp. 234-245
-
-
Norwood, M.G.1
Bown, M.J.2
Sayers, R.D.3
-
35
-
-
0027743455
-
High levels of portal TNF-alpha during abdominal aortic surgery in man
-
Cabie A., Farkas J.C., Fitting C., et al. High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine 5 5 (1993 Sep) 448-453
-
(1993)
Cytokine
, vol.5
, Issue.5
, pp. 448-453
-
-
Cabie, A.1
Farkas, J.C.2
Fitting, C.3
-
36
-
-
0034983238
-
The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair
-
Swartbol P., Truedsson L., and Norgren L. The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. European Journal of Vascular and Endovascular Surgery 21 5 (2001 May) 393-400
-
(2001)
European Journal of Vascular and Endovascular Surgery
, vol.21
, Issue.5
, pp. 393-400
-
-
Swartbol, P.1
Truedsson, L.2
Norgren, L.3
-
37
-
-
0141518220
-
Cytokine gene polymorphisms and the inflammatory response to abdominal aortic aneurysm repair
-
Bown M.J., Horsburgh T., Nicholson M.L., et al. Cytokine gene polymorphisms and the inflammatory response to abdominal aortic aneurysm repair. British Journal of Surgery 90 9 (2003 Sep) 1085-1092
-
(2003)
British Journal of Surgery
, vol.90
, Issue.9
, pp. 1085-1092
-
-
Bown, M.J.1
Horsburgh, T.2
Nicholson, M.L.3
-
38
-
-
0027732124
-
Portal endotoxin and cytokine responses during abdominal aortic surgery
-
Baigrie R.J., Lamont P.M., Whiting S., and Morris P.J. Portal endotoxin and cytokine responses during abdominal aortic surgery. American Journal of Surgery 166 3 (1993 Sep) 248-251
-
(1993)
American Journal of Surgery
, vol.166
, Issue.3
, pp. 248-251
-
-
Baigrie, R.J.1
Lamont, P.M.2
Whiting, S.3
Morris, P.J.4
-
40
-
-
25444447343
-
Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery
-
Scheingraber S., Dobbert D., Schmiedel P., et al. Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery. Surgery Today 35 10 (2005) 846-854
-
(2005)
Surgery Today
, vol.35
, Issue.10
, pp. 846-854
-
-
Scheingraber, S.1
Dobbert, D.2
Schmiedel, P.3
-
41
-
-
0034243510
-
Effect of gender and sex hormones on immune responses following shock
-
Angele M.K., Schwacha M.G., Ayala A., and Chaudry I.H. Effect of gender and sex hormones on immune responses following shock. Shock 14 2 (2000 Aug) 81-90
-
(2000)
Shock
, vol.14
, Issue.2
, pp. 81-90
-
-
Angele, M.K.1
Schwacha, M.G.2
Ayala, A.3
Chaudry, I.H.4
-
42
-
-
27744490837
-
Functional genomics and gene expression profiling in sepsis: beyond class prediction
-
Feezor R.J., Cheng A., Paddock H.N., et al. Functional genomics and gene expression profiling in sepsis: beyond class prediction. Clinical Infectious Diseases 41 Suppl. 7 (2005 Nov 15) S427-S435
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.SUPPL. 7
-
-
Feezor, R.J.1
Cheng, A.2
Paddock, H.N.3
-
44
-
-
1542613966
-
Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence
-
Anselmi A., Abbate A., Girola F., et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. European Journal of Cardio-Thoracic Surgery 25 3 (2004 Mar) 304-311
-
(2004)
European Journal of Cardio-Thoracic Surgery
, vol.25
, Issue.3
, pp. 304-311
-
-
Anselmi, A.1
Abbate, A.2
Girola, F.3
-
45
-
-
0036836660
-
Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling
-
Abbate A., Biondi-Zoccai G.G., and Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. Journal of Cellular Physiology 193 2 (2002 Nov) 145-153
-
(2002)
Journal of Cellular Physiology
, vol.193
, Issue.2
, pp. 145-153
-
-
Abbate, A.1
Biondi-Zoccai, G.G.2
Baldi, A.3
-
46
-
-
0030929714
-
Biochemical markers of myocardial injury during cardiac operations
-
Birdi I., Angelini G.D., and Bryan A.J. Biochemical markers of myocardial injury during cardiac operations. Annals of Thoracic Surgery 63 3 (1997 Mar) 879-884
-
(1997)
Annals of Thoracic Surgery
, vol.63
, Issue.3
, pp. 879-884
-
-
Birdi, I.1
Angelini, G.D.2
Bryan, A.J.3
-
47
-
-
33751306512
-
Improved postoperative outcomes associated with preoperative statin therapy
-
[quiz 89-90]
-
Hindler K., Shaw A.D., Samuels J., et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105 6 (2006 Dec) 1260-1272 [quiz 89-90]
-
(2006)
Anesthesiology
, vol.105
, Issue.6
, pp. 1260-1272
-
-
Hindler, K.1
Shaw, A.D.2
Samuels, J.3
-
49
-
-
2642521993
-
Statins as immunomodulatory agents
-
Mach F. Statins as immunomodulatory agents. Circulation 109 21 Suppl. 1 (2004 Jun 1) II15-II17
-
(2004)
Circulation
, vol.109
, Issue.21 SUPPL. 1
-
-
Mach, F.1
-
50
-
-
29144493384
-
Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease - a randomized, placebo-controlled study
-
Alber H.F., Frick M., Suessenbacher A., et al. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease - a randomized, placebo-controlled study. American Heart Journal 151 1 (2006 Jan) 139
-
(2006)
American Heart Journal
, vol.151
, Issue.1
, pp. 139
-
-
Alber, H.F.1
Frick, M.2
Suessenbacher, A.3
-
51
-
-
2942521282
-
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects
-
Bruni F., Pasqui A.L., Pastorelli M., et al. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. International Journal of Cardiology 95 2-3 (2004 Jun) 269-274
-
(2004)
International Journal of Cardiology
, vol.95
, Issue.2-3
, pp. 269-274
-
-
Bruni, F.1
Pasqui, A.L.2
Pastorelli, M.3
-
52
-
-
13844267374
-
Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation
-
Lai W.T., Lee K.T., Chu C.S., et al. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation. International Journal of Cardiology 98 3 (2005 Feb 28) 459-464
-
(2005)
International Journal of Cardiology
, vol.98
, Issue.3
, pp. 459-464
-
-
Lai, W.T.1
Lee, K.T.2
Chu, C.S.3
-
53
-
-
33749511414
-
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy
-
Patti G., Chello M., Pasceri V., et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. Journal of the American College of Cardiology 48 8 (2006 Oct 17) 1560-1566
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.8
, pp. 1560-1566
-
-
Patti, G.1
Chello, M.2
Pasceri, V.3
-
54
-
-
26844522123
-
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial
-
Ray K.K., Cannon C.P., Cairns R., et al. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology 46 8 (2005 Oct 18) 1417-1424
-
(2005)
Journal of the American College of Cardiology
, vol.46
, Issue.8
, pp. 1417-1424
-
-
Ray, K.K.1
Cannon, C.P.2
Cairns, R.3
-
55
-
-
33644692289
-
Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia
-
Li J.J., Li Y.S., Chu J.M., et al. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clinica Chimica Acta 366 1-2 (2006 Apr) 269-273
-
(2006)
Clinica Chimica Acta
, vol.366
, Issue.1-2
, pp. 269-273
-
-
Li, J.J.1
Li, Y.S.2
Chu, J.M.3
-
56
-
-
0342424181
-
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
-
Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 16 (2000 Apr 25) 1899-1906
-
(2000)
Circulation
, vol.101
, Issue.16
, pp. 1899-1906
-
-
Schachinger, V.1
Britten, M.B.2
Zeiher, A.M.3
-
57
-
-
0037007153
-
Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study
-
Gokce N., Keaney Jr. J.F., Hunter L.M., et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105 13 (2002 Apr 2) 1567-1572
-
(2002)
Circulation
, vol.105
, Issue.13
, pp. 1567-1572
-
-
Gokce, N.1
Keaney Jr., J.F.2
Hunter, L.M.3
-
58
-
-
0029007253
-
Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
-
Eichstadt H.W., Eskotter H., Hoffman I., et al. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. American Journal of Cardiology 76 2 (1995 Jul 13) 122A-125A
-
(1995)
American Journal of Cardiology
, vol.76
, Issue.2
-
-
Eichstadt, H.W.1
Eskotter, H.2
Hoffman, I.3
-
59
-
-
0031032831
-
Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
-
O'Driscoll G., Green D., and Taylor R.R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95 5 (1997 Mar 4) 1126-1131
-
(1997)
Circulation
, vol.95
, Issue.5
, pp. 1126-1131
-
-
O'Driscoll, G.1
Green, D.2
Taylor, R.R.3
-
60
-
-
2942720515
-
Beneficial cardiovascular pleiotropic effects of statins
-
Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 23 Suppl. 1 (2004 Jun 15) III39-III43
-
(2004)
Circulation
, vol.109
, Issue.23 SUPPL. 1
-
-
Davignon, J.1
-
61
-
-
0035830412
-
Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
-
Feron O., Dessy C., Desager J.P., and Balligand J.L. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103 1 (2001 Jan 2) 113-118
-
(2001)
Circulation
, vol.103
, Issue.1
, pp. 113-118
-
-
Feron, O.1
Dessy, C.2
Desager, J.P.3
Balligand, J.L.4
-
62
-
-
17344385356
-
The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells
-
Morikawa S., Takabe W., Mataki C., et al. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. Journal of Atherosclerosis and Thrombosis 9 4 (2002) 178-183
-
(2002)
Journal of Atherosclerosis and Thrombosis
, vol.9
, Issue.4
, pp. 178-183
-
-
Morikawa, S.1
Takabe, W.2
Mataki, C.3
-
63
-
-
33847163631
-
Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins
-
Igarashi J., Miyoshi M., Hashimoto T., et al. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. British Journal of Pharmacology 150 4 (2007 Feb) 470-479
-
(2007)
British Journal of Pharmacology
, vol.150
, Issue.4
, pp. 470-479
-
-
Igarashi, J.1
Miyoshi, M.2
Hashimoto, T.3
-
64
-
-
2942733214
-
Role of endothelial dysfunction in atherosclerosis
-
Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 23 Suppl. 1 (2004 Jun 15) III27-III32
-
(2004)
Circulation
, vol.109
, Issue.23 SUPPL. 1
-
-
Davignon, J.1
Ganz, P.2
-
65
-
-
0034681920
-
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
-
Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 15 (2000 Apr 18) 1767-1772
-
(2000)
Circulation
, vol.101
, Issue.15
, pp. 1767-1772
-
-
Ridker, P.M.1
Rifai, N.2
Stampfer, M.J.3
Hennekens, C.H.4
-
66
-
-
0034687438
-
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease
-
Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. The New England Journal of Medicine 343 16 (2000 Oct 19) 1139-1147
-
(2000)
The New England Journal of Medicine
, vol.343
, Issue.16
, pp. 1139-1147
-
-
Lindahl, B.1
Toss, H.2
Siegbahn, A.3
-
67
-
-
0033587667
-
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators
-
Ridker P.M., Rifai N., Pfeffer M.A., et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100 3 (1999 Jul 20) 230-235
-
(1999)
Circulation
, vol.100
, Issue.3
, pp. 230-235
-
-
Ridker, P.M.1
Rifai, N.2
Pfeffer, M.A.3
-
68
-
-
0037126043
-
Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction
-
Plenge J.K., Hernandez T.L., Weil K.M., et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 106 12 (2002 Sep 17) 1447-1452
-
(2002)
Circulation
, vol.106
, Issue.12
, pp. 1447-1452
-
-
Plenge, J.K.1
Hernandez, T.L.2
Weil, K.M.3
-
69
-
-
0036239382
-
Early initiation of treatment with statins in acute coronary syndromes
-
Olsson A.G., and Schwartz G.G. Early initiation of treatment with statins in acute coronary syndromes. Annals of Medicine 34 1 (2002) 37-41
-
(2002)
Annals of Medicine
, vol.34
, Issue.1
, pp. 37-41
-
-
Olsson, A.G.1
Schwartz, G.G.2
-
70
-
-
0036268290
-
Effects of simvastatin and atorvastatin on inflammation markers in plasma
-
Wiklund O., Mattsson-Hulten L., Hurt-Camejo E., and Oscarsson J. Effects of simvastatin and atorvastatin on inflammation markers in plasma. Journal of Internal Medicine 251 4 (2002 Apr) 338-347
-
(2002)
Journal of Internal Medicine
, vol.251
, Issue.4
, pp. 338-347
-
-
Wiklund, O.1
Mattsson-Hulten, L.2
Hurt-Camejo, E.3
Oscarsson, J.4
-
71
-
-
0035955760
-
Novel clinical markers of vascular wall inflammation
-
Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Circulation Research 89 9 (2001 Oct 26) 763-771
-
(2001)
Circulation Research
, vol.89
, Issue.9
, pp. 763-771
-
-
Blake, G.J.1
Ridker, P.M.2
-
73
-
-
0035916233
-
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization
-
Crisby M., Nordin-Fredriksson G., Shah P.K., et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 7 (2001 Feb 20) 926-933
-
(2001)
Circulation
, vol.103
, Issue.7
, pp. 926-933
-
-
Crisby, M.1
Nordin-Fredriksson, G.2
Shah, P.K.3
-
74
-
-
0034908652
-
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
-
Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. The Journal of Clinical Investigation 108 3 (2001 Aug) 391-397
-
(2001)
The Journal of Clinical Investigation
, vol.108
, Issue.3
, pp. 391-397
-
-
Dimmeler, S.1
Aicher, A.2
Vasa, M.3
-
75
-
-
0035912855
-
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
-
Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 24 (2001 Jun 19) 2885-2890
-
(2001)
Circulation
, vol.103
, Issue.24
, pp. 2885-2890
-
-
Vasa, M.1
Fichtlscherer, S.2
Adler, K.3
-
76
-
-
17944371854
-
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
-
Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America 98 18 (2001 Aug 28) 10344-10349
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.18
, pp. 10344-10349
-
-
Orlic, D.1
Kajstura, J.2
Chimenti, S.3
-
77
-
-
0034533147
-
Statins as a newly recognized type of immunomodulator
-
Kwak B., Mulhaupt F., Myit S., and Mach F. Statins as a newly recognized type of immunomodulator. Natural Medicines 6 12 (2000 Dec) 1399-1402
-
(2000)
Natural Medicines
, vol.6
, Issue.12
, pp. 1399-1402
-
-
Kwak, B.1
Mulhaupt, F.2
Myit, S.3
Mach, F.4
-
78
-
-
0030826180
-
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial
-
Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 96 5 (1997 Sep 2) 1398-1402
-
(1997)
Circulation
, vol.96
, Issue.5
, pp. 1398-1402
-
-
Wenke, K.1
Meiser, B.2
Thiery, J.3
-
79
-
-
0035838424
-
In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice
-
Laurat E., Poirier B., Tupin E., et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104 2 (2001 Jul 10) 197-202
-
(2001)
Circulation
, vol.104
, Issue.2
, pp. 197-202
-
-
Laurat, E.1
Poirier, B.2
Tupin, E.3
-
80
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 9326 (2002 Jul 6) 7-22
-
(2002)
Lancet
, vol.360
, Issue.9326
, pp. 7-22
-
-
-
81
-
-
27744560162
-
Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease
-
Biccard B.M., Sear J.W., and Foex P. Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease. Anaesthesia 60 11 (2005 Nov) 1106-1114
-
(2005)
Anaesthesia
, vol.60
, Issue.11
, pp. 1106-1114
-
-
Biccard, B.M.1
Sear, J.W.2
Foex, P.3
-
82
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
Downs J.R., Clearfield M., Weis S., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. The Journal of the American Medical Association 279 20 (1998 May 27) 1615-1622
-
(1998)
The Journal of the American Medical Association
, vol.279
, Issue.20
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
83
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
-
Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 9346 (2002 Nov 23) 1623-1630
-
(2002)
Lancet
, vol.360
, Issue.9346
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
-
84
-
-
0037132607
-
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
-
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). The Journal of the American Medical Association 288 23 (2002 Dec 18) 2998-3007
-
(2002)
The Journal of the American Medical Association
, vol.288
, Issue.23
, pp. 2998-3007
-
-
-
85
-
-
0034672571
-
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)
-
Arntz H.R., Agrawal R., Wunderlich W., et al. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). American Journal of Cardiology 86 12 (2000 Dec 15) 1293-1298
-
(2000)
American Journal of Cardiology
, vol.86
, Issue.12
, pp. 1293-1298
-
-
Arntz, H.R.1
Agrawal, R.2
Wunderlich, W.3
-
87
-
-
28144436295
-
In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits
-
Fonarow G.C. In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits. Chest 128 5 (2005 Nov) 3641-3651
-
(2005)
Chest
, vol.128
, Issue.5
, pp. 3641-3651
-
-
Fonarow, G.C.1
-
88
-
-
23944497531
-
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality
-
Fonarow G.C., Wright R.S., Spencer F.A., et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. American Journal of Cardiology 96 5 (2005 Sep 1) 611-616
-
(2005)
American Journal of Cardiology
, vol.96
, Issue.5
, pp. 611-616
-
-
Fonarow, G.C.1
Wright, R.S.2
Spencer, F.A.3
-
89
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
-
Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine 333 20 (1995) 1301-1307
-
(1995)
The New England Journal of Medicine
, vol.333
, Issue.20
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
90
-
-
33751322472
-
Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy
-
Kasai T., Miyauchi K., Kurata T., et al. Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy. International Journal of Cardiology 114 2 (2007 Jan 8) 210-217
-
(2007)
International Journal of Cardiology
, vol.114
, Issue.2
, pp. 210-217
-
-
Kasai, T.1
Miyauchi, K.2
Kurata, T.3
-
91
-
-
33847729386
-
Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide
-
McGown C.C., and Brookes Z.L. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. British Journal of Anaesthesia 98 2 (2007 Feb) 163-175
-
(2007)
British Journal of Anaesthesia
, vol.98
, Issue.2
, pp. 163-175
-
-
McGown, C.C.1
Brookes, Z.L.2
-
92
-
-
2342488799
-
Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
-
Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery 39 5 (2004) 967-975
-
(2004)
Journal of Vascular Surgery
, vol.39
, Issue.5
, pp. 967-975
-
-
Durazzo, A.E.1
Machado, F.S.2
Ikeoka, D.T.3
-
93
-
-
0032946579
-
Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG
-
[discussion 9-400]
-
Christenson J.T. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio-Thoracic Surgery 15 4 (1999 Apr) 394-399 [discussion 9-400]
-
(1999)
European Journal of Cardio-Thoracic Surgery
, vol.15
, Issue.4
, pp. 394-399
-
-
Christenson, J.T.1
-
94
-
-
33745120121
-
Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death
-
Groschel K., Ernemann U., Schulz J.B., et al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 240 1 (2006 Jul) 145-151
-
(2006)
Radiology
, vol.240
, Issue.1
, pp. 145-151
-
-
Groschel, K.1
Ernemann, U.2
Schulz, J.B.3
-
95
-
-
33646168143
-
Influence of cardiac risk factors and medication on length of hospitalization in patients undergoing major vascular surgery
-
van de Pol M.A., van Houdenhoven M., Hans E.W., et al. Influence of cardiac risk factors and medication on length of hospitalization in patients undergoing major vascular surgery. American Journal of Cardiology 97 10 (2006 May 15) 1423-1426
-
(2006)
American Journal of Cardiology
, vol.97
, Issue.10
, pp. 1423-1426
-
-
van de Pol, M.A.1
van Houdenhoven, M.2
Hans, E.W.3
-
96
-
-
33646157302
-
Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery
-
Feringa H.H., Bax J.J., Schouten O., and Poldermans D. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery. Seminars in Cardiothoracic and Vascular Anesthesia 10 1 (2006 Mar) 25-31
-
(2006)
Seminars in Cardiothoracic and Vascular Anesthesia
, vol.10
, Issue.1
, pp. 25-31
-
-
Feringa, H.H.1
Bax, J.J.2
Schouten, O.3
Poldermans, D.4
-
97
-
-
33845465199
-
Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies
-
Kapoor A.S., Kanji H., Buckingham J., et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ (Clinical Research Ed.) 333 7579 (2006 Dec 2) 1149
-
(2006)
BMJ (Clinical Research Ed.)
, vol.333
, Issue.7579
, pp. 1149
-
-
Kapoor, A.S.1
Kanji, H.2
Buckingham, J.3
-
98
-
-
2342564429
-
Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery
-
Lindenauer P.K., Pekow P., Wang K., et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. The Journal of the American Medical Association 291 17 (2004) 2092-2099
-
(2004)
The Journal of the American Medical Association
, vol.291
, Issue.17
, pp. 2092-2099
-
-
Lindenauer, P.K.1
Pekow, P.2
Wang, K.3
-
99
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
-
Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. The Journal of the American Medical Association 285 13 (2001 Apr 4) 1711-1718
-
(2001)
The Journal of the American Medical Association
, vol.285
, Issue.13
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
-
100
-
-
4544243333
-
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial
-
de Lemos J.A., Blazing M.A., Wiviott S.D., et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. The Journal of the American Medical Association 292 11 (2004 Sep 15) 1307-1316
-
(2004)
The Journal of the American Medical Association
, vol.292
, Issue.11
, pp. 1307-1316
-
-
de Lemos, J.A.1
Blazing, M.A.2
Wiviott, S.D.3
-
101
-
-
0342470555
-
Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment
-
Hogue Jr. C.W., and Hyder M.L. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Annals of Thoracic Surgery 69 1 (2000 Jan) 300-306
-
(2000)
Annals of Thoracic Surgery
, vol.69
, Issue.1
, pp. 300-306
-
-
Hogue Jr., C.W.1
Hyder, M.L.2
-
103
-
-
33846065206
-
Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins
-
Blanchard L., and Collard C.D. Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins. Current Opinion in Anaesthesiology 20 1 (2007 Feb) 53-56
-
(2007)
Current Opinion in Anaesthesiology
, vol.20
, Issue.1
, pp. 53-56
-
-
Blanchard, L.1
Collard, C.D.2
-
104
-
-
0346995016
-
Inflammation as a risk factor for atrial fibrillation
-
Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 24 (2003 Dec 16) 3006-3010
-
(2003)
Circulation
, vol.108
, Issue.24
, pp. 3006-3010
-
-
Aviles, R.J.1
Martin, D.O.2
Apperson-Hansen, C.3
-
105
-
-
29244441972
-
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting
-
Marin F., Pascual D.A., Roldan V., et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. American Journal of Cardiology 97 1 (2006 Jan 1) 55-60
-
(2006)
American Journal of Cardiology
, vol.97
, Issue.1
, pp. 55-60
-
-
Marin, F.1
Pascual, D.A.2
Roldan, V.3
-
106
-
-
0034670114
-
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting
-
A6
-
Dotani M.I., Elnicki D.M., Jain A.C., and Gibson C.M. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. American Journal of Cardiology 86 10 (2000) 1128-1130 A6
-
(2000)
American Journal of Cardiology
, vol.86
, Issue.10
, pp. 1128-1130
-
-
Dotani, M.I.1
Elnicki, D.M.2
Jain, A.C.3
Gibson, C.M.4
-
107
-
-
33749505716
-
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study
-
Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 114 14 (2006 Oct 3) 1455-1461
-
(2006)
Circulation
, vol.114
, Issue.14
, pp. 1455-1461
-
-
Patti, G.1
Chello, M.2
Candura, D.3
-
108
-
-
33846843787
-
Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation
-
Ozaydin M., Dogan A., Varol E., et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 107 2 (2007) 117-121
-
(2007)
Cardiology
, vol.107
, Issue.2
, pp. 117-121
-
-
Ozaydin, M.1
Dogan, A.2
Varol, E.3
-
109
-
-
28144431640
-
Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein
-
Amar D., Zhang H., Heerdt P.M., et al. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128 5 (2005 Nov) 3421-3427
-
(2005)
Chest
, vol.128
, Issue.5
, pp. 3421-3427
-
-
Amar, D.1
Zhang, H.2
Heerdt, P.M.3
-
110
-
-
0036548601
-
Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature
-
Naylor A.R., Mehta Z., Rothwell P.M., and Bell P.R. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. European Journal of Vascular and Endovascular Surgery 23 4 (2002 Apr) 283-294
-
(2002)
European Journal of Vascular and Endovascular Surgery
, vol.23
, Issue.4
, pp. 283-294
-
-
Naylor, A.R.1
Mehta, Z.2
Rothwell, P.M.3
Bell, P.R.4
-
111
-
-
33745950533
-
Predictive factors of stroke in patients undergoing coronary bypass grafting: statins are protective
-
Aboyans V., Labrousse L., Lacroix P., et al. Predictive factors of stroke in patients undergoing coronary bypass grafting: statins are protective. European Journal of Cardio-Thoracic Surgery 30 2 (2006 Aug) 300-304
-
(2006)
European Journal of Cardio-Thoracic Surgery
, vol.30
, Issue.2
, pp. 300-304
-
-
Aboyans, V.1
Labrousse, L.2
Lacroix, P.3
-
112
-
-
0031005723
-
Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
-
Blauw G.J., Lagaay A.M., Smelt A.H., and Westendorp R.G. Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28 5 (1997 May) 946-950
-
(1997)
Stroke
, vol.28
, Issue.5
, pp. 946-950
-
-
Blauw, G.J.1
Lagaay, A.M.2
Smelt, A.H.3
Westendorp, R.G.4
-
113
-
-
0035665697
-
The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery
-
[discussion S5-6, S7-70]
-
Menasche P. The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Annals of Thoracic Surgery 72 6 (2001 Dec) S2260-S2265 [discussion S5-6, S7-70]
-
(2001)
Annals of Thoracic Surgery
, vol.72
, Issue.6
-
-
Menasche, P.1
-
115
-
-
29144528068
-
Preoperative statin therapy and troponin T predict early complications of coronary artery surgery
-
Pascual D.A., Arribas J.M., Tornel P.L., et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Annals of Thoracic Surgery 81 1 (2006 Jan) 78-83
-
(2006)
Annals of Thoracic Surgery
, vol.81
, Issue.1
, pp. 78-83
-
-
Pascual, D.A.1
Arribas, J.M.2
Tornel, P.L.3
-
116
-
-
33644596337
-
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study
-
Clark L.L., Ikonomidis J.S., Crawford Jr. F.A., et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. The Journal of Thoracic and Cardiovascular Surgery 131 3 (2006 Mar) 679-685
-
(2006)
The Journal of Thoracic and Cardiovascular Surgery
, vol.131
, Issue.3
, pp. 679-685
-
-
Clark, L.L.1
Ikonomidis, J.S.2
Crawford Jr., F.A.3
-
117
-
-
23044467734
-
Preoperative statin use and outcomes following cardiac surgery
-
Ali I.S., and Buth K.J. Preoperative statin use and outcomes following cardiac surgery. International Journal of Cardiology 103 1 (2005 Aug 3) 12-18
-
(2005)
International Journal of Cardiology
, vol.103
, Issue.1
, pp. 12-18
-
-
Ali, I.S.1
Buth, K.J.2
-
118
-
-
0242490858
-
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
-
Genest J., Frohlich J., Fodor G., and McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Canadian Medical Association Journal 169 9 (2003 Oct 28) 921-924
-
(2003)
Canadian Medical Association Journal
, vol.169
, Issue.9
, pp. 921-924
-
-
Genest, J.1
Frohlich, J.2
Fodor, G.3
McPherson, R.4
-
119
-
-
0042512336
-
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
-
De Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal 24 17 (2003 Sep) 1601-1610
-
(2003)
European Heart Journal
, vol.24
, Issue.17
, pp. 1601-1610
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
-
120
-
-
1542327997
-
Lipid management guidelines - 2001. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand
-
Lipid management guidelines - 2001. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand. Medical Journal of Australia 175 Suppl (2001 Nov 5) S57-S85
-
(2001)
Medical Journal of Australia
, vol.175
, Issue.SUPPL
-
-
-
121
-
-
33745302444
-
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
-
Manuel D.G., Kwong K., Tanuseputro P., et al. Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. BMJ (Clinical Research Ed.) 332 7555 (2006 Jun 17) 1419
-
(2006)
BMJ (Clinical Research Ed.)
, vol.332
, Issue.7555
, pp. 1419
-
-
Manuel, D.G.1
Kwong, K.2
Tanuseputro, P.3
-
122
-
-
13444293056
-
The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002
-
Teeling M., Bennett K., and Feely J. The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002. British Journal of Clinical Pharmacology 59 2 (2005 Feb) 227-232
-
(2005)
British Journal of Clinical Pharmacology
, vol.59
, Issue.2
, pp. 227-232
-
-
Teeling, M.1
Bennett, K.2
Feely, J.3
-
124
-
-
0141612021
-
Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams
-
Brewer Jr. H.B. Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams. American Journal of Cardiology 92 4B (2003 Aug 21) 23K-29K
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.4 B
-
-
Brewer Jr., H.B.1
-
125
-
-
10644230170
-
Statin safety in perspective - maximising the risk:benefit
-
Evans M. Statin safety in perspective - maximising the risk:benefit. British Journal of Cardiology 11 6 (2004) 449-454
-
(2004)
British Journal of Cardiology
, vol.11
, Issue.6
, pp. 449-454
-
-
Evans, M.1
-
129
-
-
0011933958
-
Controversy surrounding the safety of cerivastatin
-
Davidson M.H. Controversy surrounding the safety of cerivastatin. Expert Opinion on Drug Safety 1 3 (2002 Sep) 207-212
-
(2002)
Expert Opinion on Drug Safety
, vol.1
, Issue.3
, pp. 207-212
-
-
Davidson, M.H.1
-
130
-
-
33845876333
-
Risks associated with statin therapy: a systematic overview of randomized clinical trials
-
Kashani A., Phillips C.O., Foody J.M., et al. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 114 25 (2006 Dec 19) 2788-2797
-
(2006)
Circulation
, vol.114
, Issue.25
, pp. 2788-2797
-
-
Kashani, A.1
Phillips, C.O.2
Foody, J.M.3
-
131
-
-
33748534819
-
Who should receive a statin these days? Lessons from recent clinical trials
-
Shepherd J. Who should receive a statin these days? Lessons from recent clinical trials. Journal of Internal Medicine 260 4 (2006 Oct) 305-319
-
(2006)
Journal of Internal Medicine
, vol.260
, Issue.4
, pp. 305-319
-
-
Shepherd, J.1
-
132
-
-
33947305508
-
Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure
-
Baber U., Toto R.D., and de Lemos J.A. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. American Heart Journal 153 4 (2007 Apr) 471-477
-
(2007)
American Heart Journal
, vol.153
, Issue.4
, pp. 471-477
-
-
Baber, U.1
Toto, R.D.2
de Lemos, J.A.3
-
133
-
-
0141986521
-
Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function - a flow cytometry study
-
Neubauer H., Gunesdogan B., Hanefeld C., et al. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function - a flow cytometry study. European Heart Journal 24 19 (2003 Oct) 1744-1749
-
(2003)
European Heart Journal
, vol.24
, Issue.19
, pp. 1744-1749
-
-
Neubauer, H.1
Gunesdogan, B.2
Hanefeld, C.3
-
134
-
-
13844276750
-
Safety of perioperative statin use in high-risk patients undergoing major vascular surgery
-
Schouten O., Kertai M.D., Bax J.J., et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. American Journal of Cardiology 95 5 (2005) 658-660
-
(2005)
American Journal of Cardiology
, vol.95
, Issue.5
, pp. 658-660
-
-
Schouten, O.1
Kertai, M.D.2
Bax, J.J.3
-
135
-
-
27744571898
-
The pharmaco-economics of peri-operative statin therapy
-
Biccard B.M., Sear J.W., and Foex P. The pharmaco-economics of peri-operative statin therapy. Anaesthesia 60 11 (2005 Nov) 1059-1063
-
(2005)
Anaesthesia
, vol.60
, Issue.11
, pp. 1059-1063
-
-
Biccard, B.M.1
Sear, J.W.2
Foex, P.3
-
136
-
-
0027962504
-
Cost-effectiveness analysis in heart disease, part I: general principles
-
Kupersmith J., Holmes-Rovner M., Hogan A., et al. Cost-effectiveness analysis in heart disease, part I: general principles. Progress in Cardiovascular Diseases 37 3 (1994 Nov-Dec) 161-184
-
(1994)
Progress in Cardiovascular Diseases
, vol.37
, Issue.3
, pp. 161-184
-
-
Kupersmith, J.1
Holmes-Rovner, M.2
Hogan, A.3
-
137
-
-
0037229731
-
A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom
-
Buller N., Gillen D., Casciano R., et al. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom. Pharmacoeconomics 21 Suppl. 1 (2003) 25-32
-
(2003)
Pharmacoeconomics
, vol.21
, Issue.SUPPL. 1
, pp. 25-32
-
-
Buller, N.1
Gillen, D.2
Casciano, R.3
-
138
-
-
0038100257
-
How cost-effective are new preventive strategies for cardiovascular disease?
-
Probstfield J.L. How cost-effective are new preventive strategies for cardiovascular disease?. American Journal of Cardiology 91 10A (2003 May 22) 22G-27G
-
(2003)
American Journal of Cardiology
, vol.91
, Issue.10 A
-
-
Probstfield, J.L.1
-
139
-
-
84865080709
-
Should statins be discontinued preoperatively? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit
-
Grant P.J., and Kedia N. Should statins be discontinued preoperatively? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit. Cleveland Clinic Journal of Medicine 73 Electronic Suppl. 1 (2006 Sep) S9-S10
-
(2006)
Cleveland Clinic Journal of Medicine
, vol.73
, Issue.Electronic SUPPL. 1
-
-
Grant, P.J.1
Kedia, N.2
-
140
-
-
34249106454
-
The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery
-
Le Manach Y., Godet G., Coriat P., et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesthesia and Analgesia 104 6 (2007 Jun) 1326-1333
-
(2007)
Anesthesia and Analgesia
, vol.104
, Issue.6
, pp. 1326-1333
-
-
Le Manach, Y.1
Godet, G.2
Coriat, P.3
-
141
-
-
6444234849
-
There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients
-
McGowan M.P. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 110 16 (2004 Oct 19) 2333-2335
-
(2004)
Circulation
, vol.110
, Issue.16
, pp. 2333-2335
-
-
McGowan, M.P.1
-
142
-
-
0037177167
-
Withdrawal of statins increases event rates in patients with acute coronary syndromes
-
Heeschen C., Hamm C.W., Laufs U., et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105 12 (2002 Mar 26) 1446-1452
-
(2002)
Circulation
, vol.105
, Issue.12
, pp. 1446-1452
-
-
Heeschen, C.1
Hamm, C.W.2
Laufs, U.3
-
143
-
-
0344272945
-
Withdrawal of statins in patients with acute coronary syndromes
-
Heeschen C., Hamm C.W., Laufs U., et al. Withdrawal of statins in patients with acute coronary syndromes. Circulation 107 3 (2003 Jan 28) e27
-
(2003)
Circulation
, vol.107
, Issue.3
-
-
Heeschen, C.1
Hamm, C.W.2
Laufs, U.3
-
144
-
-
0037178764
-
Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice
-
Vecchione C., and Brandes R.P. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circulation Research 91 2 (2002 Jul 26) 173-179
-
(2002)
Circulation Research
, vol.91
, Issue.2
, pp. 173-179
-
-
Vecchione, C.1
Brandes, R.P.2
-
145
-
-
33748996772
-
Discontinuation of statin treatment in stroke patients
-
Endres M., and Laufs U. Discontinuation of statin treatment in stroke patients. Stroke 37 10 (2006 Oct) 2640-2643
-
(2006)
Stroke
, vol.37
, Issue.10
, pp. 2640-2643
-
-
Endres, M.1
Laufs, U.2
-
146
-
-
33746228324
-
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery
-
Collard C.D., Body S.C., Shernan S.K., et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. The Journal of Thoracic and Cardiovascular Surgery 132 2 (2006 Aug) 392-400
-
(2006)
The Journal of Thoracic and Cardiovascular Surgery
, vol.132
, Issue.2
, pp. 392-400
-
-
Collard, C.D.1
Body, S.C.2
Shernan, S.K.3
-
147
-
-
33645214077
-
Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy
-
Li J.J., Li Y.S., Chen J., and Yang J.Q. Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy. Medical Hypotheses 66 6 (2006) 1199-1204
-
(2006)
Medical Hypotheses
, vol.66
, Issue.6
, pp. 1199-1204
-
-
Li, J.J.1
Li, Y.S.2
Chen, J.3
Yang, J.Q.4
-
148
-
-
33748100587
-
Statin withdrawal: clinical implications and molecular mechanisms
-
Cubeddu L.X., and Seamon M.J. Statin withdrawal: clinical implications and molecular mechanisms. Pharmacotherapy 26 9 (2006 Sep) 1288-1296
-
(2006)
Pharmacotherapy
, vol.26
, Issue.9
, pp. 1288-1296
-
-
Cubeddu, L.X.1
Seamon, M.J.2
-
149
-
-
33645046407
-
Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal
-
Taneva E., Borucki K., Wiens L., et al. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. American Journal of Cardiology 97 7 (2006 Apr 1) 1002-1006
-
(2006)
American Journal of Cardiology
, vol.97
, Issue.7
, pp. 1002-1006
-
-
Taneva, E.1
Borucki, K.2
Wiens, L.3
-
151
-
-
22444446997
-
Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study
-
Hudson M., Richard H., and Pilote L. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study. BMJ (Clinical Research Ed.) 330 7504 (2005 Jun 11) 1370
-
(2005)
BMJ (Clinical Research Ed.)
, vol.330
, Issue.7504
, pp. 1370
-
-
Hudson, M.1
Richard, H.2
Pilote, L.3
|